Classes
- Malignancies of B and T lymphocytes +6CCOC8959 | Third Faculty of Medicine
- Student Research ActivityC3SVA0061 | Third Faculty of Medicine
- Summer Practice in Compulsory FieldC5VL017 | Third Faculty of Medicine
- ?CCOC5938 | Third Faculty of Medicine
- . +1CCOC5938L | Third Faculty of Medicine
- Autoimune endocrinopathiesCCOC6922 | Third Faculty of Medicine
- Clinical Manifestation of Immune DisordersCCOC71S | Third Faculty of Medicine
- Basic skills in Emergency medical service +1CCOCA0004 | Third Faculty of Medicine
- Basic skill of physician in emergency dutiesCCOCA0023 | Third Faculty of Medicine
- Principles of Evidence-based Medicine and Basic research TrainingCCVOL25 | Third Faculty of Medicine
Publications
- Characteristics and outcome of patients with core binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study2022 | Third Faculty of Medicine
- Deciphering the complex circulating immune cell microenvironment in chronic lymphocytic leukaemia using patient similarity networks2021 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- The impact of centralised care of younger AML patients on treatment results: a retrospective analysis of real-world data from a national population-based registry2021 | Central Library of Charles University
- 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy2021 | Third Faculty of Medicine
- Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group2020 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Characteristics and results of treatment of younger patients less than 60 years old with AML: analysis of real data from the Czech DATOOL-AML database2020 | Central Library of Charles University, Third Faculty of Medicine
- Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial2020 | Third Faculty of Medicine
- Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab2019 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial2019 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts2019 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...